PNEUMOVAX 23 sol inj 1 pce
7680656750035
CH-65675
J07AL01
08.08.
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6567501
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- polysaccharida streptococci pneumoniae typus 1 25 µg, polysaccharida streptococci pneumoniae typus 3 25 µg, polysaccharida streptococci pneumoniae typus 4 25 µg, polysaccharida streptococci pneumoniae typus 5 25 µg, polysaccharida streptococci pneumoniae typus 6B 25 µg, polysaccharida streptococci pneumoniae typus 7F 25 µg, polysaccharida streptococci pneumoniae typus 8 25 µg, polysaccharida streptococci pneumoniae typus 9N 25 µg, polysaccharida streptococci pneumoniae typus 9V 25 µg, polysaccharida streptococci pneumoniae typus 10A 25 µg, polysaccharida streptococci pneumoniae typus 11A 25 µg, polysaccharida streptococci pneumoniae typus 12F 25 µg, polysaccharida streptococci pneumoniae typus 14 25 µg, polysaccharida streptococci pneumoniae typus 15B 25 µg, polysaccharida streptococci pneumoniae typus 17F 25 µg, polysaccharida streptococci pneumoniae typus 20 25 µg, polysaccharida streptococci pneumoniae typus 22F 25 µg, polysaccharida streptococci pneumoniae typus 23F 25 µg, polysaccharida streptococci pneumoniae typus 33F 25 µg, natrii chloridum corresp. natrium 1.8 mg, phenolum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.
Articles (1)
Pneumovax-23, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
polysaccharida streptococci pneumoniae typus 1
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 3
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 4
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 5
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 6B
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 7F
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 8
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 9N
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 9V
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 10A
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 11A
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 12F
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 14
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 15B
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 17F
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 20
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 22F
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 23F
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
polysaccharida streptococci pneumoniae typus 33F
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
1.8 MG | Substance | HBESI |
|
phenolum
|
- | Substance | Konservierungsstoff (Conservateur) |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 65675
- Drug name
- Pneumovax-23, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- J07AL01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/02/2016
- Authorization expiration date
- 31/12/2026
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PNEUMOVAX 23 sol inj 1 pce
- Description (DE)
- PNEUMOVAX 23 Inj Lös 1 Stk
- Market launch
- 26/02/2016
- Narcotic (BTM)
- No